VSR Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
$1.32M Sell
39,479
-32,101
-45% -$1.02M 0.22% 134
2016
Q1
$2.01M Buy
71,580
+14,071
+24% +$402K 0.21% 125
2015
Q4
$1.76M Buy
57,509
+22,186
+63% +$698K 0.19% 139
2015
Q3
$1.05M Buy
35,323
+3,564
+11% +$114K 0.12% 196
2015
Q2
$1.01M Buy
31,759
+1,910
+6% +$62.3K 0.11% 220
2015
Q1
$985K Sell
29,849
-4,407
-13% -$140K 0.11% 212
2014
Q4
$1.01M Sell
34,256
-3,319
-9% -$95.2K 0.11% 199
2014
Q3
$1.05M Sell
37,575
-2,633
-7% -$73.9K 0.13% 184
2014
Q2
$1.13M Sell
40,208
-4,845
-11% -$138K 0.14% 167
2014
Q1
$1.37M Sell
45,053
-3,342
-7% -$99.6K 0.19% 130
2013
Q4
$1.41M Buy
48,395
+533
+1% +$15.5K 0.22% 113
2013
Q3
$1.3M Sell
47,862
-3,738
-7% -$102K 0.23% 105
2013
Q2
$1.37M Buy
+51,600
New +$1.43M 0.27% 92

Other funds holding PFE

VSR Financial Services's PFE Position: Q2 2016 in Review

VSR Financial Services reduced its Pfizer (PFE) stake by 45% in Q2 2016, selling an estimated $1.02M and leaving 39,479 shares worth $1.32M. The position accounts for 0.22% of the portfolio, ranked #134.

VSR Financial Services first reported a position in PFE in Q2 2013 and has held it in 13 quarters since. The position peaked at $2.01M in Q1 2016. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

  • VSR Financial Services held 39,479 shares of Pfizer worth $1.32M as of Q2 2016.
  • VSR Financial Services sold 32,101 Pfizer shares in Q2 2016, an estimated $1.02M.
  • Pfizer made up 0.22% of VSR Financial Services's portfolio in Q2 2016, its #134 holding.
  • VSR Financial Services first reported a position in Pfizer in Q2 2013 and has held it in 13 quarters since.
  • VSR Financial Services's Pfizer position peaked at $2.01M in Q1 2016.
  • 1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on VSR Financial Services's 13F filing for Q2 2016, filed 11 Aug 2016.